Fibroscan-based score to predict liver fibrosis in patients with liver disease and its correlation with anthropometric measurements

Abstract

Introduction: Progressive hepatic fibrosis with the improvement of cirrhosis is a function of nearly all persistent liver diseases. Transient elastography (TE) using Fibro Scan now permits for a speedy size of liver stiffness.
Material and methods: Between Dec 2020 and Dec 2021, all consecutive sufferers with continual liver ailments considered at the branch of generic medicinal drug AIIMS, Bhatinda, had been prospectively included. Patients have been enrolled after written knowledgeable consent was once obtained. For all patients, the following clinical, organic and morphological parameters have been decided at the time of the liver stiffness measurement.
Results: Correlation is giant at the 0.01 degree (2-tailed) in SBP, DBP, BMI, and HbA1C. Correlation is full-size at the 0.05 degree (2-tailed) in creatinine, and VLDL. Conclusion: TE using fibroscan gives a convincible choice as compared to the use of liver biopsy in diagnostic evaluation of fibrosis, cirrhosis, and persistent liver diseases.

Keywords: Liver fibrosis, Fibro Scan, Transient Elastography, Anthropometric measurements.